Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

Supporting the lab of the future, MilliporeSigma partners with Opentrons Labworks, Inc

of Merck KGaA, Darmstadt, Germany is a proven leader in terms of the breadth and quality of products they offer for pharmaceutical development and manufacturing, and we’re excited to combine that with our ability to provide world-class automation,...

Lutris Pharma secures $30 million in financing to advance the development of a biopharmaceutical aimed at improving the effectiveness of anti-cancer drugs

Lutris Pharma, a clinical stage biopharmaceutical company focused on improving anti-cancer therapies by reducing cutaneous dose-limiting toxicity, announced that it has secured a $30 million financing to advance the development of LUT014, an...

Cellipont Bioservices and Secretome Therapeutics partner for cGMP manufacturing of the Master Cell Bank for their lead asset, STM-01

our clients and the communities we serve. About Secretome Therapeutics: Secretome Therapeutics is a clinical-stage biopharmaceutical company pioneering the development of therapeutics derived from neonatal cardiac progenitor cells (nCPC) to treat...

West introduces Daikyo PLASCAP® RUV closures in a new nested format at Pharmapack

West Pharmaceutical Services, Inc. a global leader in innovative solutions for injectable drug administration, announced the introduction of Daikyo PLASCAP® Ready-to-Use Validated (RUV) closures in a new nested format available in multiple...

MalarVx licenses HDT Bio's repRNA/LION™ technology to develop a groundbreaking malaria vaccine

and cost-effective vaccine to prevent malaria is desperately needed. HDT Bio Corp. is a clinical-stage biopharmaceutical company specializing in advanced RNA vaccine technologies, including the company's proprietary LION nanoparticle delivery...

Quantum-Si launches Platinum® Pro, the end-to-end solution for gaining deeper insights in proteomics

Platinum. It introduces advanced features specifically tailored to address the evolving needs of researchers and biopharmaceutical customers. Its key innovations include: Streamlined User Experience: Platinum Pro features an enlarged touchscreen...

Signaling exciting growth, Modular Devices welcomes Jason Thompson and Stephanie Powers Kurtz to the Cleanrooms Sales Team

experience in sales, business development, and go-to-market strategies within the life sciences, healthcare, and biopharmaceutical industries. Previously, Jason led the global sales strategy for Trane Technologies' Life Science Solutions Team,...

NTx announces the full commercial availability of NTxscribe to broadly enable RNA therapies

shortening timelines for bringing new therapies and vaccines to market and empowering researchers, biotech, and pharmaceutical companies to make personalized medicine a reality. “Our team has worked closely with NTx and utilized the innovative...

Dr. Alastair Leighton, a biopharma veteran, has been hired as Chief Operating Officer by Chemify

as Chief Operating Officer (COO). With almost three decades in the biopharma industry working at leading global pharmaceutical companies, Dr. Leighton brings a wealth of experience in manufacturing, supply chain operations and commercial strategy....

RiDYMO® develops a cyclic peptide targeting the "undruggable" β-catenin in just two months

its potential to accelerate the development of orally available cyclic peptide drugs, potentially transforming the pharmaceutical industry's approach to challenging targets. This breakthrough in cyclic peptide design for β-catenin showcases the...

NLS Pharmaceutics and Kadimastem announce a $500,000 initial closing of a $1 million fundraising, with shares priced at $3.10, a 48% premium over the January 6, 2025 market price

NLS Pharmaceutics Ltd. a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for rare and complex central nervous system disorders, and Kadimastem Ltd. "Kadimastem", a clinical-stage cell...

Cardurion Pharmaceuticals has named Charlotte Newman as Chief Business Officer

Cardurion Pharmaceuticals, Inc. a clinical-stage biotechnology company discovering and developing new therapeutic approaches for the treatment of cardiovascular diseases, today announced that Charlotte (Charlie) Newman has joined the company as...

Axio BioPharma Partners with eMBR Genomics to Manufacture and Distribute Proprietary MKLP1 Pro™ Antibodies

manufacturing and flexible production capabilities to support a wide range of clients, including researchers, pharmaceutical companies, and diagnostic developers, in achieving streamlined workflows and consistent, high-quality outcomes. About eMBR...

"Fresenius Kabi expands its U.S. pharma portfolio with the launch of Epinephrine Injection, USP

Leadership Team, Fresenius Kabi AG. Fresenius Kabi has invested nearly $1 billion to expand and update its U.S. pharmaceutical production and distribution facilities. Fresenius Kabi is committed to domestic production. More than 70 percent of the...

Isotopia collaborates with LIVEKIDNEY.BIO, marking a breakthrough in lupus treatment advancements

and safer treatment options than those currently available. About Isotopia: Isotopia is a global leader in radiopharmaceutical solutions, specializing in high-quality aseptic and lyophilized drug products for clinical trials and commercial use....

MM+M honors Petauri's Nicole Lodowski as a 2025 40 Under 40 awardee

Petauri, a leading purpose-built pharmaceutical services platform, announced that Nicole Lodowski, Managing Director of Petauri Evidence, has been recognized as one of MM+M's esteemed 40 Under 40 honorees for 2025. Amanda Peterson, Vice President...

Pilatus Biosciences Inc. earns FDA Orphan Drug Designation for PLT012, targeting liver and intrahepatic bile duct cancer

regulatory authorities to expedite PLT012's development and availability. Pilatus Biosciences, a preclinical-stage biopharmaceutical company spun out from the Ludwig Institute for Cancer Research (Lausanne), is leading the development of...

Biolexis Therapeutics reports positive outcomes for BLX-7006 in an expanded Diet-Induced Obesity (DIO) model study

lives of those affected by chronic metabolic diseases." About Biolexis Therapeutics: Biolexis Therapeutics is a biopharmaceutical company focused on discovering and developing innovative metabolic drugs to address chronic diseases such as obesity,...

SciTech Development reveals promising Phase 1A trial results for T-cell non-Hodgkin lymphoma therapy

SciTech Development, a clinical-stage pharmaceutical company focused on advancements in cancer treatment, is excited to share promising updates from its clinical trial of ST-001 nanoFenretinide (ST-001). Preliminary Trial Findings: Preliminary...

Dr. Jonathan Sadeh, ex-SVP of Immunology R&D at Bristol-Myers Squibb, joins Scinai Immunotherapeutics' Scientific Advisory Board

Scinai Immunotherapeutics Ltd. a biopharmaceutical company focused on developing inflammation and immunology (I&I) biological products and providing CDMO services through its Scinai Bioservices business unit, announced that Dr. Jonathan Sadeh has...